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Endothelial differentiationCytokines play important roles in cardiac repair and regeneration. Recently, we demonstrated that inter-
leukin (IL)-6 family cytokines induce the endothelial differentiation of Sca-1+ cardiac resident stem cells
through STAT3/Pim-1 signaling pathway. In contrast, the biological functions of IL-12 family cytokines in
heart remain to be elucidated, though they show structural homology with IL-6. In the present study, we
examined the effects of IL-12 family cytokines on the transdifferentiation of cardiac Sca-1+ cells into car-
diac cells. RT-PCR analyses revealed that IL-27 receptor a (IL-27Ra), but not IL-12R or IL-23R, was
expressed in cardiac Sca-1+ cells. The transcript expression of IL-27 was elevated in murine hearts in car-
diac injury models. Intriguingly, IL-27 stimulation for 14 days induced the endothelial cell (EC) marker
genes, such as CD-31 and VE-cadherin. Immunoblot analyses clariﬁed that IL-27 treatment rapidly phos-
phorylated STAT3. IL-27 upregulated the expression of Pim-1, but the overexpression of dominant neg-
ative STAT3 abrogated the induction of Pim-1 by IL-27. Finally, adenoviral transfection of dominant
negative Pim-1 inhibited IL-27-induced EC differentiation of cardiac Sca-1+ cells. These ﬁndings demon-
strated that IL-27 promoted the commitment of cardiac stem cells into the EC lineage, possibly leading to
neovascularization as a novel biological function. IL-27 could not only regulate the inﬂammation but also
contribute to the maintenance of the tissue homeostasis through stem cell differentiation at inﬂamma-
tory sites.
 2015 The Authors. Published by Elsevier Ltd. This is anopenaccess article under the CCBY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Accumulating evidence has revealed that IL-6 family cytokines
play important roles in vascular formation. IL-6 cytokines bind to
their speciﬁc receptor and gp130, followed by STAT3 activation.
The activation of STAT3 induces angiogenic factors, such as VEGF,
increasing capillary vessels [1] in the normal or cancer tissues
[2–5]. In addition, we have recently demonstrated that IL-6 family
cytokines induce endothelial differentiation of Sca-1+ cardiac resi-
dent stem cells [6,7], suggesting that IL-6 family cytokines con-
tribute to neovascularization not only by stimulating pre-existing
ECs but also by regulating commitment of tissue resident stem
cells into ECs. In Sca-1+ cardiac resident stem cells, the activation
of STAT3 is essential for the EC differentiation induced by IL-6 fam-
ily cytokines. Activated STAT3 rapidly upregulates the expression
of Pim-1 serine/threonine kinase as a critical event for the transd-
ifferentiation [8]. Importantly, the transplantation of cardiacSca-1+ cells in post-infarct myocardium resulted in the increased
capillary density, while not the Sca-1+ cells transfected with dom-
inant negative Pim-1.
Recently, much attention has been paid to IL-12 family cytoki-
nes as regulators of inﬂammation [9,10]. IL-12 cytokine family,
which is composed of IL-12, IL-23, IL-27, and IL-35, is evolutionar-
ily linked to the IL-6 cytokine superfamily. The members of the
IL-12 family are heterodimeric proteins consisting of alpha and
beta chains. The alpha chains, such as p19, p28, and p35, share
structural homology with IL-6, whereas the beta chains, p40 or
Epstein–Barr virus-induced gene 3 (EBI3), with soluble cytokine
receptor chains, such as IL-6Ra. These cytokines transduce signals
through unique heterodimeric receptors, leading to the activation
of JAK-STAT pathways. Interestingly, it was reported that
IL-27Ra, also designated as WSX-1, is highly expressed in the
heart, though its biological function remains to be addressed [11].
In the present study, we examined the functional signiﬁcances
of IL-27/IL-27Ra by focusing on cardiac resident stem cells. Here,
we found that IL-27 induced the endothelial differentiation in car-
diac Sca-1+ cells as a novel biological function. This is the ﬁrst
Table 1
The primers used in this study.
Genes Direction Sequence
VE-cadherin Forward 50-ATCTTCCTCTGCATCCTCAC-30
Reverse 50-GTAAGTGACCAACTGCTCGT-30
CD31 Forward 50-GAGCCCAATCACGTTTCAGTTT-30
Reverse 50-TCCTTCCTGCTTCTTGCTAGCT-30
Flk-1 Forward 50-TGCCGGCATGGTCTTCTGTGAGG-30
Reverse 50-CATTGAGCTCTGTTCTCGCTGTAC-30
Nkx-2.5 Forward 50-CAGTGGAGCTGGACAAAGCC-30
Reverse 50-TTGTAGCGACGGTTCTGGAA-30
Calponin Forward 50-GCACATTTTAACCGAGGTCC-30
Reverse 50-TGACCTTCTTCACAGAACCC-30
IL-12Rb1 Forward 50-CAGGGACCAGCAAACACATC-30
Reverse 50-TTCCTGGGTCCTAAGGGTGA-30
IL-12Rb2 Forward 50-GACTCGACAGCACAACCTGA-30
Reverse 50-TTGGGGACTTTCACCAGCAG-30
IL-23R Forward 50-TTGGTATGGGTCCAAGCTGT-30
Reverse 50-TCGTTTGTAGTCTCAGCCCT-30
IL-27R Forward 50-AAGGGACCAGGAAACCGTTG-30
Reverse 50-AATCCCCAAACTGAGGGTGC-30
p28 Forward 50-AGCCTGTTGCTGCTACCCTTGC-30
Reverse 50-GTGGACATAGCCCTGAACCTCA-30
EBI3 Forward 50-TCTTCCTGTCACTTGCCCTCTG-30
Reverse 50-AGTTGGGAGCCTGGAGAGGAGT-30
GAPDH Forward 50-CATCACCATCTTCCAGGAGCG-30
Reverse 50-GAGGGGCCATCCACAGTCTTC-30
366 T. Tanaka et al. / Cytokine 75 (2015) 365–372demonstration that IL-27 regulates the cell fate of cardiac resident
stem cells.
2. Materials and method
2.1. Animal experiments
The animal experiments were approved by the Institutional
Animal Care and Use Committee of Graduate School of
Pharmaceutical Sciences, Osaka University (Permit Number;
DOUYAKU 19-32-6). The investigation is compliance with the
Guide for the Care and Use of Laboratory Animal published by
the US National Institutes of Health (National Institutes of Health
publication No. 85-23. revised 1996).
2.2. Preparation of cardiac Sca-1+ cells and cytokine treatment
Cardiac Sca-1+ cells were isolated by magnetic cell sorting
(MACS) from wild type C57Bl/6 mice (8–10 weeks old, Japan SLC)
with about 98% purity, as previously described [6].
Recombinant mouse IL-27 (#2799-ML-010) was purchased
from R&D systems. Isolated cardiac Sca-1+ cells were treated with
IL-27 at different concentrations for the indicated time.
2.3. Induction of myocardial infarction and experimental autoimmune
myocarditis
Myocardial infarction (MI) was generated by ligation of the left
anterior descending coronary artery according to previous report
with minor modiﬁcations [12]. In brief, C57/Bl6 mice were anes-
thetized and ventilated with 100% oxygen containing 1.5% isoﬂu-
rane. After left-side thoracotomy, the left coronary artery was
ligated with 7-0 silk sutures. The chest and the skin were closed
with 5-0 silk sutures. At days 0, 4, 7 and 14 after MI, mice were sac-
riﬁced, followed by analysis of gene expressions in hearts.
Experimental autoimmune myocarditis (EAM) was induced as
described previously [13]. Brieﬂy, BALB/c mice were immunized
with peptides derived from the sequence of the murine a-cardiac
myosin heavy chain (Myhc). Myhc-a peptides, diluted in PBS, were
emulsiﬁed in complete Freund’s adjuvant. On days 0 and 7, 100 lg
of Myhc-a peptides in 200 lL of the emulsion was subcutaneously
treated. At days 0, 14, 21 and 28 after ﬁrst immunization, gene
expressions in hearts were measured by quantitative RT-PCR, as
described below.
2.4. RT-PCR analyses/quantitative RT-PCR analyses
RT-PCR was performed as previously described [6]. Brieﬂy, total
RNA was prepared from cardiac Sca-1+ cells with acid guanidinium
thiocyanate-phenol-chloroform method. Total RNA (1 lg) was
subjected for the ﬁrst strand cDNA synthesis by using the oligo
(dT) ﬁrst strand primer. Gene-speciﬁc primers used for PCR
ampliﬁcation were shown in Table 1. The PCR products were
size-fractionated by 2% agarose gel electrophoresis.
After synthesis of the ﬁrst strand cDNA, quantitative PCR was
performed with the use of Applied Biosystems StepOne™
Real-Time PCR System (Applied Biosystems, CA) with the FAST
SYBR Green PCR Master Mix (Applied Biosystems, CA). GAPDH
was used as an internal control.
2.5. Immunoblot analyses
Immunoblot analyses were performed as described previously
[6]. Cell lysates were prepared by adding SDS-PAGE sample solu-
tion to cells and boiled for 5 min. Proteins were separated bySDS-PAGE on polyacrylamide gels and transferred to polyvinyli-
dene diﬂuoride membranes (Millipore). The membrane was
blocked with 2% skim milk for 1 h, followed by incubation with
anti-phospho-STAT3 (#9131, Cell Signaling Technology),
anti-phospho-ERK1/2 (#9101, Cell Signaling Technology), or
anti-Pim-1 (#3247, Cell Signaling Technology) antibody, as a pri-
mary antibody, overnight at 4 C. Horseradish peroxidase
(HRP)-conjugated antibody (Santa Cruz Biotechnology) was used
as secondary antibody. The bands were detected by ECL system
(GE Healthcare). Densitometric analyses of the detected bands
were performed with Image-J software. The membrane was
reprobed with anti-STAT3 antibody (sc-7179, Santa Cruz
Biotechnology), anti-ERK1/2 (#9102, Cell Signaling Technology),
or anti-GAPDH antibody (MAB374, Millipore) to show equal
amount of protein loading.2.6. Immunoﬂuorescent microscopic analyses
Immunoﬂuorescent microscopic analyses were performed as
described previously [14]. Brieﬂy, cells were ﬁxed with 3.7%
formaldehyde in PBS for 20 min at room temperature, followed
by staining with anti-Sca-1 (R&D Systems), IL-27Ra (Abcam) and
anti-VE-cadherin antibodies (sc-6458, Santa Cruz Biotechnology).
Alexa Fluor 488- or 546-conjugated secondary antibody
(Molecular Probes) was used for detection. Nuclei were also
stained with Hoechst 33258 (Sigma). Cells were examined with
ﬂuorescent microscopy (Olympus FSX100).2.7. Construction and infection of adenovirus vectors
The construction of adenovirus vectors expressing dominant
negative form of STAT3 (dn-STAT3), dominant-negative form of
Pim-1 (dn-Pim-1), and b-galactosidase fused with a nuclear local-
ization signal (b-gal) was previously described [2,8]. Sca-1+ cells
were infected with adenovirus vectors at a multiplicity of infection
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Fig. 1. IL-27Ra (WSX-1) was expressed in cardiac Sca-1+ cells. Cardiac Sca-1+ cells were isolated from C57Bl/6 mice. (A) The expressions of IL-12Rb1, IL-12Rb2, IL-23R and IL-
27Ra (WSX-1) in Sca-1+ cells were examined by RT-PCR. Total RNA from murine spleen was used as a positive control. GAPDH was used as an internal control. (B) The
expression of IL-27Ra protein was detected by immunoﬂuorescent microscopic analysis. Representative images are shown. Bar = 100 lm.
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Fig. 2. Transcript expression of IL-27 was upregulated in murine hearts of cardiac injury models. The expression of p28 and EBI3, which are components of IL-27 cytokine, in
MI hearts (A) and EAM hearts (B) were analyzed by quantitative RT-PCR. GAPDH was used as the internal control. Data were shown as mean ± S.E. (N = 3–8 for MI model,
N = 6–8 for EAM model). ⁄P < 0.05 by Steel’s test versus day 0.
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conditions.
2.8. Statistical analysis
Statistical analysis was performed by unpaired t-test, ANOVA
with post-hoc multiple comparison test or Steel’s test. A value of
less than 0.05 was considered signiﬁcant. Data were shown as
the mean value ± standard error (S.E.).
3. Result
3.1. IL-27 cytokine induced the expression of the EC speciﬁc markers in
cardiac Sca-1+ cells
To address the effects of the IL-12 family cytokines on the dif-
ferentiation of cardiac Sca-1+ cells, we ﬁrst examined the0 0.2
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Fig. 3. IL-27 induces EC markers, but not cardiomyocyte marker and smooth muscle cell
concentrations of IL-27 for 14 days. (A and B) RT-PCR assay was performed for CD31, VE-
positive control. Representative data are shown. Experiments were repeated four times
The expressions of these genes were normalized with that of GAPDH. Data are shown as
Williams test versus 0 ng/ml. (C) Immunocytochemical analysis was performed with
independent cell cultures. Bar = 100 lm. VE-cadherin positive cells were quantitatively eexpression of the receptors for these cytokines in cardiac Sca-1+
cells by RT-PCR (Fig. 1A). IL-27Ra mRNA was expressed in cardiac
Sca-1+ cells, while the transcripts of IL-12Rb1, IL-12Rb2, and
IL-23Rwere not detected. By immunoﬂuorescent microscopic anal-
yses, we have conﬁrmed that more than 90% of cardiac Sca-1+ cells
expressed IL-27Ra protein (Fig. 1B). Thus, we focused on IL-27
functions in further experiments of this study.
Previously, we have reported that the upregulation of IL-6 fam-
ily cytokines is likely to induce EC differentiation of Sca-1+ cells
after MI [7,8]. To explore the possibility that cardiac Sca-1+ cells
could be stimulated with IL-27 under pathophysiological condi-
tion, we examined the gene expression proﬁles of p28 and EBI3,
which are components of IL-27, in murine hearts using two exper-
imental disease models. Quantitative RT-PCR analyses revealed
that both genes were signiﬁcantly upregulated in post-infarct
hearts (Fig. 2A). Moreover, the increase of these gene transcripts
was also observed in EAM hearts (Fig. 2B).2.0 20
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cadherin, Nkx-2.5, calponin and GAPDH. Total RNA from murine hearts was used as a
with similar results. Quantitative RT-PCR was performed for CD31 and VE-cadherin.
mean ± S.E. from four independent experiments. ⁄⁄P < 0.01 by ANOVA followed by
anti-VE-cadherin antibody. The images are representative of 75 ﬁelds from three
stimated. Data are shown as mean ± S.E. ⁄⁄P < 0.01 by Student t test versus 0 ng/ml.
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plex composed of IL-27Ra and glycoprotein 130 (gp130).
Previously, we have demonstrated that gp130 is expressed in car-
diac Sca-1+ cells [7]. Therefore, we examined whether IL-27
induces the endothelial differentiation. Cardiac Sca-1+ cells were
cultured with IL-27 for 14 days. RT-PCR analyses revealed that
the expression of the endothelial marker genes, such as
VE-cadherin, CD31, and ﬂk-1, was upregulated, whereas the expres-
sion of cardiomyocyte or smooth muscle cell speciﬁc marker genes,
Nkx-2.5 and calponin, was not detected in either the presence or
absence of IL-27 (Fig. 3A). Quantitative RT-PCR analyses demon-
strated that the expression of EC-speciﬁc markers, VE-cadherin
and CD31, was upregulated in response to IL-27 (20 ng/ml)
(VE-cadherin: 4.6-fold, CD31: 4.7-fold compared with control,
n = 4) (Fig. 3B). Moreover, immunoﬂuorescent microscopic analy-
ses have revealed that about 10% of Sca-1+ cells, cultured with
IL-27 for 14 days, were positively stained with anti-VE-cadherin
antibody (Fig. 3C). These ﬁndings suggest that IL-27Ra functionally
transduces their signals and that stimulation of IL-27Ra with IL-27
results in endothelial differentiation in cardiac Sca-1+ cells.
3.2. IL-27 activated STAT3/Pim-1 axis in cardiac Sca-1+ cells
Previously, we reported that STAT3/Pim-1 pathway plays a crit-
ical role in endothelial differentiation of cardiac Sca-1+ cells by IL-6B 
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Fig. 4. IL-27 activates STAT3 in cardiac Sca-1+ cells. (A) Cardiac Sca-1+ cells were stimul
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to show the equal amount loading. Representative data are shown in the left panel. Quan
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30 min. Phosphorylation of STAT3 and ERK was examined by immunoblot analyses, as de
by densitometry were shown in the right panel. Data are shown as mean ± S.E. from thre
0 ng/ml.family cytokines both in vitro and in vivo [8]. To investigate the
importance of STAT3/Pim-1 signaling in IL-27-mediated commit-
ment of cardiac Sca-1+ cells to EC lineage, we examined whether
IL-27 activates STAT3/Pim-1 axis in cardiac Sca-1+ cells.
Cardiac Sca-1+ cells were stimulated with IL-27 for the indi-
cated time, and phosphorylation of STAT3 was analyzed by
immunoblotting with anti-phospho-STAT3 antibody (Fig. 4A).
STAT3 was prominently phosphorylated by IL-27, reaching a peak
within 30 min of stimulation, and their activities were reduced to
the basal level 60 min after stimulation, whereas the phosphoryla-
tion of ERK1/2 was not signiﬁcantly enhanced. Moreover, STAT3
was phosphorylated by IL-27 in a dose-dependent manner
(Fig. 4B).
Next, we examined whether IL-27 induces Pim-1 in cardiac
Sca-1+ cells (Fig. 5A and B). Quantitative RT-PCR analysis con-
ﬁrmed that the expression of Pim-1 transcript was signiﬁcantly
upregulated 30 min after IL-27 stimulation and returned to base-
line within 3 h, followed by the reactivation afterward. The expres-
sion of Pim-1 mRNA was enhanced in a dose-dependent manner.
Western blot analyses conﬁrmed that Pim-1 protein level was
increased by IL-27 treatment.
Since Pim-1 kinase is a downstream target of STAT3 in cardiac
Sca-1+ cells [8], we investigated whether STAT3 activation is
required for Pim-1 induction by IL-27 (Fig. 6A and B). Adenoviral
gene transfer of dominant-negative STAT3 (dn-STAT3) abrogated0
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370 T. Tanaka et al. / Cytokine 75 (2015) 365–372IL-27-mediated induction of Pim-1 mRNA and protein, while the
upregulation of Pim-1 expression by IL-27 was observed in
the cells expressing b-galactosidase (b-gal), a control. These
ﬁndings indicate that STAT3 activation is necessary for Pim-1
induction by IL-27.3.3. STAT3/Pim-1 axis is required for IL-27-mediated commitment of
cardiac Sca-1+ cells to EC lineage
To examine whether Pim-1 activation is essential for the
endothelial differentiation of cardiac Sca-1+ cells by IL-27, we
T. Tanaka et al. / Cytokine 75 (2015) 365–372 371analyzed the effects of the inhibition of Pim-1 by adenoviral vec-
tors expressing dominant negative Pim-1 (dn-Pim-1)
(Fig. 7A and B). IL-27 failed to induce the endothelial differentia-
tion in dn-Pim-1-expressing cells, whereas endothelial-speciﬁc
genes were upregulated by IL-27 in the cells expressing b-gal.
The inhibition of Pim-1 signaling did not inﬂuence the expression
of cardiomyocyte or smooth muscle cell marker genes, Nkx-2.5 and
calponin. These data indicate that STAT3/Pim-1 plays functional
roles in IL-27-induced ECs differentiation in vitro.
4. Discussion
In this study, we examined the biological effects of IL-27 on the
transdifferentiation of Sca-1+ cardiac resident stem cells. Here, we
showed that IL-27Ra was expressed in cardiac resident stem cells.
Additionally, the expression of IL-27 transcript was upregulated in
MI and EAM hearts. Importantly, the stimulation of IL-27Ra with
IL-27 resulted in endothelial differentiation in cardiac resident
stem cells. To our knowledge, this is the ﬁrst demonstration that
IL-27 exhibits its biological function in tissue resident stem cells.
WSX-1 was originally cloned as a novel orphan receptor, based
on the similarity of cDNA sequence to the cytokine class I receptor
family [11], and characterized as a component of IL-27R, IL-27Ra,
afterward [15]. Interestingly, Northern blot analyses demonstrated
that WSX-1 is highly expressed in the heart [11]; however, biolog-
ical functions of IL-27 in the heart remain to be addressed, because
IL-27 has been mainly considered as an immunoregulator. In this
study, we discovered that cardiac Sca-1+ resident stem cells
expressed IL-27Ra and that IL-27 transduced the differentiation
signals in cardiac Sca-1+ cells. We also found that IL-27Ra was
expressed in cardiac myocytes (data not shown). We will discuss
the functional signiﬁcances of IL-27Ra in cardiomyocytes
elsewhere.0
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Fig. 7. Adenoviral overexpression of dominant negative Pim-1 abrogated IL-27-induced
adenovirus vector expressing dominant negative Pim-1 (dn-Pim-1) or b-gal and incubated
cell differentiation into cardiac cells were analyzed by RT-PCR. (B) Quantitative RT-PC
normalized with that of GAPDH. Data are shown as mean ± S.E. from four independent exSo far, it has been thought that hearts have the limited regener-
ative capacity, because cardiac myocytes cease to proliferate
immediately after birth. However, recent studies identiﬁed several
kinds of cardiac resident stem cells, such as Sca-1+ cells and c-kit+
cells [16,17]. These cells can differentiate into cardiac cells, includ-
ing ECs, smooth muscle cells and cardiac myocytes, suggesting that
cardiac resident stem cells can play crucial roles in cardiac
repair/regeneration. Previously, we demonstrated that IL-6 family
cytokines induces the endothelial differentiation of Sca-1+ cells
through STAT3/Pim-1 pathway [8]. Here, similar to IL-6 family
cytokines, IL-27 activated STAT3/Pim-1 pathway in Sca-1+ cardiac
resident stem cells, leading to the transdifferentiation into the ECs.
Importantly, the transplantation of cardiac Sca-1+ stem cells into
myocardium attenuated adverse cardiac remodeling after myocar-
dial injury, while cardiac Sca-1+ cells, whose STAT3/Pim-1 signal-
ing pathway was inhibited, failed to exhibit cardioprotective
effects [8]. Thus, the activation of STAT3/Pim-1 by IL-27 or other
cytokines in cardiac Sca-1+ cells is likely to be a novel strategy that
enhances cardiac repair/regeneration.
Here, we have demonstrated that IL-27 transcript expression
was elevated in murine MI hearts. Interestingly, the expression of
IL-27 peaked from days 7 to 14 after MI., while IL-6 family cytoki-
nes, such as IL-11 and LIF, increased in the hearts immediately
after MI [7], suggesting IL-27 might function as an activator of
STAT3 in later phase of MI, compared with IL-6 family cytokines.
Recently, it has been demonstrated that serum level of IL-27 is
increased in the patients with acute myocardial infarction, com-
pared with the control [18], proposing the clinical relevance of
the importance of IL-27 in cardiovascular diseases.
The termination of inﬂammatory reactions is followed by tissue
repair/regeneration. A number of studies have demonstrated
that IL-27 exhibits immunoregulatory effects in experimental0
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EC differentiation in cardiac Sca-1+ cells. Cardiac Sca-1+ cells were transfected with
with or without IL-27 (20 ng/ml) for 14 days. (A) The effects of dn-Pim-1 on Sca-1+
R was performed for VE-cadherin and CD31. The expressions of these genes were
periments. ⁄P < 0.05, ⁄⁄P < 0.01 by one-way ANOVA followed by Tukey–Kramer test.
372 T. Tanaka et al. / Cytokine 75 (2015) 365–372autoimmune diseases [19–24]. For example, IL-27 suppresses
the inﬂammatory reaction in experimental autoimmune
encephalomyelitis (EAE) [19,20]. IL-27R-deﬁcient mice are suscep-
tible to EAE with the increased Th17 cells. Similarly, the expression
of IL-27 attenuates collagen-induced arthritis [21]. Interestingly,
these experimental autoimmune models are self-limiting. The tis-
sue damage, induced by inﬂammatory reaction, is repaired after
the inﬂammatory process terminates. Considering the regenerative
property of IL-27 on cardiac resident stem cells as a non-immune
function, our data could propose a possibility that IL-27 con-
tributes to the link between the tissue repair/regeneration and
the termination of inﬂammatory reactions in hearts.
In conclusion, IL-27 induces the endothelial differentiation in
cardiac resident stem cells through STAT3/Pim-1 signaling path-
way. These ﬁndings suggest that IL-27/IL-27R system could be a
therapeutic target that might link the regulation of inﬂammatory
reaction with tissue repair/regeneration in cardiovascular diseases.
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